Partex.AI Technology logo — The experts in AI technology for drug discovery and developm...

Partex.AI Technology

The experts in AI technology for drug discovery and development.

Founded 2011 India Pune, India 182 employees Series C AI, Analytics +6

General Information

Company Name Partex.AI Technology
Founded Year 2011
Location India Pune, India
Founders / Decision Makers
Team member
Employees 182
Industries AI, Analytics, Biotechnology +5
Funding Stage Series C
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Service Fee, Licensing
Offices as of Oct 2026
Pune, India Frankfurt, Germany
Social

BounceWatch is an independent company data service, not affiliated with Partex.AI Technology. To contact Partex.AI Technology, visit partex.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Partex.AI Technology compare?

A PDF of Partex.AI Technology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Partex.AI Technology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Partex.AI Technology

Partex.AI Technology leverages artificial intelligence to aid drug discovery and development for pharmaceutical companies, biotechnology firms, and contract research organizations. Headquartered in Eschborn, Germany, with offices in Pune, India, and the USA, it employs AI, machine learning, and blockchain technologies.

Founded in 2011, Partex.AI Technology offers services such as AI-powered drug discovery, therapeutic asset development, and real-world data integration. It operates on a B2B, SaaS, and platform business model, generating revenue through subscription fees, service fees, and licensing. The company focuses on biomedical data analysis, clinical trial optimization, and regulatory compliance to streamline the drug development process.

Business keywords: AI in Drug Discovery, Machine Learning in Life Sciences, Biomedical Data Analysis, Clinical Trial Optimization, Regulatory Compliance in Pharma, Ontology-Based Data Models, Cost Reduction in Drug Development, Continuous Decision-Making Solutions, Structured and Unstructured Data Analytics, Pharmaceutical Data Aggregation, DaaS Solutions for Pharma, CaaS for Business Outcomes, Blockchain in Life Sciences, Network Analysis in Drug Development, Entity Normalization

Services & Products

AI-Powered Drug Discovery
Therapeutic Asset Development
Data-Driven Pipeline Optimization
In- and Out-Licensing Solutions
High-Throughput Experimental Screening
Real-World Data Integration

Target Customers

Pharmaceutical Companies Biotechnology Firms Contract Research Organizations (CROs) Healthcare Providers Research Institutions Technology Leaders in Life Sciences

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Undisclosed -
01 Apr 2019
Early VC Undisclosed 1
Christian Angermayer
01 Mar 2017
Early VC Undisclosed -
01 Dec 2016
Corporate Spinout Undisclosed 1
Partex
01 Sep 2015

Partex.AI Technology Alternatives & Competitors

View All Alternatives
Partex.AI Technology vs
Terray Therapeutics
Terray Therapeutics United States

Everything small molecule drug discovery should be.

Series B
142 employees
AI, Biopharma
Partex.AI Technology vs
Cellarity
Cellarity United States

Rewriting the rules of drug creation

Series C
76 employees
Biotechnology, Life Sciences
Partex.AI Technology vs

Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small...

Seed
14 employees
Biotechnology, Life Sciences

FAQ About Partex.AI Technology

The experts in AI technology for drug discovery and development.
Partex.AI Technology was founded in 2011.
Partex.AI Technology is headquartered in Pune, India. As of Oct 2026, it also has offices in Frankfurt, Germany.
Partex.AI Technology operates in AI, Analytics, Biotechnology, Blockchain, Information Technology, Life Sciences, Pharmaceutical and Machine Learning. Its work centres on AI in Drug Discovery, Machine Learning in Life Sciences, Biomedical Data Analysis and Clinical Trial Optimization. Its customers include Pharmaceutical Companies, Biotechnology Firms and Contract Research Organizations (CROs).
Partex.AI Technology has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Service Fee and Licensing.
Partex.AI Technology has approximately 182 employees.
Partex.AI Technology has completed 4 funding rounds. The latest funding stage is Series C.
Partex.AI Technology offers: AI-Powered Drug Discovery, Therapeutic Asset Development, Data-Driven Pipeline Optimization, In- and Out-Licensing Solutions, High-Throughput Experimental Screening, Real-World Data Integration.
Top alternatives and competitors to Partex.AI Technology include Terray Therapeutics, Cellarity, PharmEnable Therapeutics, SyntheticGestalt, Insilico Medicine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Partex.AI Technology and Terray Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Partex.AI Technology, https://bouncewatch.com/company/innoplexus, updated 1 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes